Patents by Inventor Erik T. Engelson

Erik T. Engelson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6066158
    Abstract: This is a surgical device usually delivered through an intravascular catheter. It is designed to pierce and remove emboli often found in tortuous vasculature. The device includes several sections. The device has a core element. Placed around the distal end of the core wire is a collapsible but self expanding embolism collection assembly. That collector assembly is typically joined to the core wire at its distal end. The collector assembly may have a generally conical distal portion when expanded and may have a proximal section having varied purposes, e.g. for centering the collector assembly in the vascular lumen. The assembly further may have an actuator which permits the collector assembly to expand after deployment.
    Type: Grant
    Filed: July 25, 1996
    Date of Patent: May 23, 2000
    Assignee: Target Therapeutics, Inc.
    Inventors: Erik T. Engelson, Gene Samson
  • Patent number: 6033423
    Abstract: This is an implantable vaso-occlusive device. It is a complex, helically wound coil having multiple secondary layers of primary windings. The final shape is often chunky in nature and may be used in the approximate shape of an anatomical cavity. It may be deployed in the approximate shape of a sphere, an ovoid, or other distorted spherical shape. The device is a self-forming shape made from a pre-formed linear vaso-occlusion member. Fibers may be introduced onto the device and affixed to the pre-formed linear member. The constituent member may be also be covered with a fibrous braid. The device is typically introduced through a catheter. The device is passed axially through the catheter sheath and assumes its form upon exiting the catheter without further action. The invention also includes methods of winding the anatomically shaped vaso-occlusive device into appropriately shaped forms and annealing them to form various devices.
    Type: Grant
    Filed: November 19, 1997
    Date of Patent: March 7, 2000
    Assignee: Target Therapeutics, Inc.
    Inventors: Christopher G. M. Ken, Erik T. Engelson
  • Patent number: 6030369
    Abstract: This is a catheter having a shaft, the layers of which are coextruded in an intermittently changing pattern that produces particular mechanical and frictional properties in the structure. The outer layer of the catheter shaft is comprised of a material which has greater flexibility than the material which comprises the inner layer of the catheter shaft. The stiffer material which comprises the inner layer has frictional properties which facilitate guidewire passage and control. The invention includes the substituent shaft per se and a method of making the shaft.
    Type: Grant
    Filed: July 3, 1997
    Date of Patent: February 29, 2000
    Assignee: Target Therapeutics Inc.
    Inventors: Erik T. Engelson, Mark Carter
  • Patent number: 6024754
    Abstract: This is a procedure for stabilizing or filling an aneurysm in the vasculature. The procedure involves the introduction into the aneurysm of a solid vaso-occlusive device such as a coil or braid and a polymeric composition which may be reformed or solidified in situ. The solid vaso-occlusive device is at least partially surrounded or enveloped by that polymeric composition. The polymeric composition is reformed via light, heat, R.F. or the like to form a rigid mass with the solid vaso-occlusive device. These steps may be carried out sequentially or the steps of introducing the vaso-occlusive device and reforming the polymeric composition may be carried out simultaneously. The procedure may be accomplished using intravascular catheters to access the desired site and to deliver the noted materials.
    Type: Grant
    Filed: October 2, 1997
    Date of Patent: February 15, 2000
    Assignee: Target Therapeutics Inc.
    Inventor: Erik T. Engelson
  • Patent number: 6022340
    Abstract: This is a catheter assembly having an expandable balloon adjustably positionable over a polymeric delivery catheter shaft.
    Type: Grant
    Filed: June 12, 1998
    Date of Patent: February 8, 2000
    Assignee: Target Therapeutics Inc.
    Inventors: Ivan Sepetka, Erik T. Engelson
  • Patent number: 6004338
    Abstract: This is an implantable vaso-occlusive device. It is typically a vaso-occlusive coil comprised of a primary helically wound coil which may then be wound into a secondary shape. Central to the invention is the use of a stretch-resisting member fixedly attached within at least a portion of the primary coil. The stretch-resisting member may be formed into coil tips at the ends of the coil by melting the polymeric fibers or alloys or by attaching the fibers with a glue. This stretch-resisting member is for the primary purpose of preventing stretching of the coil during movement of that coil, e.g., by retrieval or repositioning after deployment. The device typically has a self-forming secondary shape made from a pre-formed primary linear helically wound coil, although it need not have the secondary form. External fibers may be attached to the device and affixed to the pre-formed linear member to increase . The vaso-occlusive member may be also be covered with a fibrous braid.
    Type: Grant
    Filed: August 11, 1998
    Date of Patent: December 21, 1999
    Assignee: Target Therapeutics Inc.
    Inventors: Christopher G. M. Ken, Son M. Gia, Erik T. Engelson
  • Patent number: 5984929
    Abstract: This is an implant for placement in the human body and an assembly for so placing that implant. Most desirably, it is an implant for use in the vasculature of the human body and is used to occlude some space in that vasculature as a portion of a treatment regimen. The implant itself is preferably a component of a deployment device using an electrolytically severable joint. The implant is electrically isolated from the electrolytically severable joint by a highly resistive or insulative layer. Such isolation and minimization of the conductive pathway from the placement apparatus to the body's fluids appears to enhance the susceptibility of the electrolytic joint to quick erosion and detachment of the implant from the deployment media. Although the implant itself is preferably a vaso-occlusive device, it may instead be a stent, a vena cava filter, or other implant which may be installed in this manner.
    Type: Grant
    Filed: September 30, 1997
    Date of Patent: November 16, 1999
    Assignee: Target Therapeutics, Inc.
    Inventors: Mehran Bashiri, Michael P. Wallace, Pete Phong Pham, Cong Thach, Chad C. Roue, Erik T. Engelson
  • Patent number: 5984878
    Abstract: This is a surgical instrument. It is a guidewire made of a stainless steel alloy core which is coated with a non-hydrophilic lubricious polymer on the majority of its length located proximally and a hydrophilic polymer located at the majority of the remaining distal length of the guidewire. Preferably, the guidewire has a polymeric tie layer located between the metallic core of the guidewire assembly and the hydrophilic polymeric layer. The metallic core is one of a number of stainless steels so to preserve its torque transmitting capabilities. Desirably the outside diameter of the guidewire is constant from the distal end to the proximal end. The metallic core may be tapered at appropriate locations along the guidewire assembly.
    Type: Grant
    Filed: August 12, 1997
    Date of Patent: November 16, 1999
    Assignee: Target Therapeutics, Inc.
    Inventor: Erik T. Engelson
  • Patent number: 5980514
    Abstract: This is an artificial occlusion kit for implanting and retaining an artificial occlusion device in a body space adjacent to and extending from a body lumen in a mammal. The includes at least one occlusion device and a retaining device for blocking the migration of the occlusion device out of the occlusion site. The retaining device is radially expandable at a retaining site adjacent the body space to be occluded to a diameter that is sufficient to engage the body lumen wall at the retaining site and form a barrier across the entrance zone of the body space to be occluded. The expanded retaining device also forms a lumen for flow through body lumen at the retaining site. At least one semi-penetrable space may also be provided in the retaining device, allowing introduction of occlusion devices into the body space to be occluded, but preventing subsequent migration of the occlusion devices out of the body space.
    Type: Grant
    Filed: July 26, 1996
    Date of Patent: November 9, 1999
    Assignee: Target Therapeutics, Inc.
    Inventors: David Kupiecki, Clifford Teoh, Hong Doan, Son M. Gia, Erik T. Engelson, Uriel Hiram Chee, Mehran Bashiri, Joseph C. Eder
  • Patent number: 5972019
    Abstract: This is a medical device. In particular, it is a surgical device usually delivered through an intravascular catheter. It may be used in several ways. It may, for instance, be used to open a clear passageway adjacent thrombus to allow both blood and medication to bypass the clot. It may be used to pierce and to remove thrombus. These thrombus are often found in tortuous vasculature. The device includes several sections. The device has a core element, typically a core wire. Placed around the distal end of the core element is a collapsible but preferably self expanding cage assembly. The cage assembly is preferably radio-opaque. The proximal end of the cage is typically is affixed to an actuator in such a way as to allow expansion of the cage after deployment. The cage assembly may have a generally conical distal or "trailing" portion when expanded and also a proximal section. The cage assembly may be used for collecting emboli or for displacing them to allow blood flow to resume.
    Type: Grant
    Filed: June 5, 1997
    Date of Patent: October 26, 1999
    Assignee: Target Therapeutics, Inc.
    Inventors: Erik T. Engelson, Gene Samson, Kim Nguyen, Rose Y. Wong
  • Patent number: 5971975
    Abstract: This is a guide catheter assembly. The guide catheter assembly is used to cooperate with a micro-catheter in accessing a tissue target within the body, typically a target which is accessible through the vascular system. Central to the invention is the use of a braided metallic reinforcing member, situated within the catheter body in such a way to create a catheter section having an exceptionally thin wall, controlled stiffness, and high resistance to kinking. The catheter has a terminal segment which is not supported by a braid and the polymer making up that terminal segment is either the same hardness as is the polymer making up the outer covering of next more adjacent section or, preferably, the polymer is harder than is the polymer making up the segment located just proximally of that terminal segment. The braid may have a single pitch or may vary in pitch along the axis of the catheter or catheter section. The braided reinforcing member typically is embedded in a flexible outer tubing member.
    Type: Grant
    Filed: October 9, 1996
    Date of Patent: October 26, 1999
    Assignee: Target Therapeutics, Inc.
    Inventors: Timothy C. Mills, Rhoda M. Santos, Erik T. Engelson, Henry Nita
  • Patent number: 5951539
    Abstract: This invention is a surgical device. In particular, it is a catheter suitable for accessing a tissue target within the body, typically a target which is accessible through the vascular system. Central to the invention is the use of at least pair of wound or counterwound reinforcing members situated within the wall of the catheter body in such a way to achieve a catheter having an exceptionally thin wall, excellent kink-resistance, and controlled stiffness.
    Type: Grant
    Filed: December 19, 1997
    Date of Patent: September 14, 1999
    Assignee: Target Therpeutics, Inc.
    Inventors: Henry Nita, Lex P. Jansen, Peter Kyone Park, Gene Samson, Erik T. Engelson, Jeffrey A. Sarge
  • Patent number: 5944733
    Abstract: A vasoocclusive member, such as embolic coil, that mechanically joins an instrument for delivering that vasoocclusive member to a selected site within the vasculature or other lumen of a human body via the use of a catheter is provided. A thermoplastic member augments the junction to enhance variously the friction at an integrity of the junction. Once the vasoocclusive member is delivered to the desired site, radio frequency energy is supplied to the thermoplastic member in an amount sufficient to soften the thermoplastic member, allowing mechanical disengagement to then take place.
    Type: Grant
    Filed: July 14, 1997
    Date of Patent: August 31, 1999
    Assignee: Target Therapeutics, Inc.
    Inventor: Erik T. Engelson
  • Patent number: 5906606
    Abstract: This is a balloon catheter having braided layer which extends generally from the proximal end of the catheter to a location distal of the balloon. In particular, it is desirable that the shaft of the catheter proximal of the balloon be stiffest at the proximal section and least stiff just proximal of the balloon. Although the catheter may be a single lumen catheter using some type of a core wire to act as a valve for inflation and deflation of the balloon, it is within the scope of the invention to include either a separate inflation/deflation lumen or one incorporated into the various concentric polymeric layers used to make up the proximal shaft. Particularly preferred is the use of an elastic, compliant balloon.
    Type: Grant
    Filed: February 27, 1996
    Date of Patent: May 25, 1999
    Assignee: Target Therapuetics, Inc.
    Inventors: Uriel Hiram Chee, Erik T. Engelson, Gene Samson
  • Patent number: 5882334
    Abstract: This is a catheter assembly having an expandable balloon adjustably positionable over a polymeric delivery catheter shaft.
    Type: Grant
    Filed: December 4, 1995
    Date of Patent: March 16, 1999
    Assignee: Target Therapeutics, Inc.
    Inventors: Ivan Sepetka, Erik T. Engelson
  • Patent number: 5853418
    Abstract: This is an implantable vaso-occlusive device. It is typically a vaso-occlusive coil comprising a primary helically wound coil which may then be wound into a secondary shape. Central to the invention is the use of a stretch-resisting member extending through the lumen formed, which stretch-resisting member is fixedly attached, directly or indirectly, to the coil in at least two locations. The stretch resisting member is preferably somewhat loose within the interior of the lumen so to prevent the coil from collapsing, binding, and therefore stiffening during passage of turns through the human body. The coil should bend easily. In some variations of the invention, the stretch-resisting member may be formed into coil tips at the ends of the coil using simple equipment such as soldering irons or the like. The tips are typically of the same diameter as is the coil body itself. This stretch-resisting member is for the primary purpose of preventing stretching of the coil during movement of that coil, e.g.
    Type: Grant
    Filed: January 7, 1997
    Date of Patent: December 29, 1998
    Assignee: Target Therapeutics, Inc.
    Inventors: Christopher G.M. Ken, Son M. Gia, Erik T. Engelson, Joseph C. Eder, Clifford Teoh
  • Patent number: 5833705
    Abstract: This is an implantable vaso-occlusive device. It is typically a vaso-occlusive coil comprised of a primary helically wound coil which may then be wound into a secondary shape. Central to the invention is the use of a stretch-resisting member fixedly attached within at least a portion of the primary coil. The stretch-resisting member may be formed into coil tips at the ends of the coil by melting the polymeric fibers or alloys or by attaching the fibers with a glue. This stretch-resisting member is for the primary purpose of preventing stretching of the coil during movement of that coil, e.g., by retrieval or repositioning after deployment. The device typically has a self-forming secondary shape made from a pre-formed primary linear helically wound coil, although it need not have the secondary form. External fibers may be attached to the device and affixed to the pre-formed linear member to increase. The vaso-occlusive member may be also be covered with a fibrous braid.
    Type: Grant
    Filed: September 20, 1996
    Date of Patent: November 10, 1998
    Assignee: Target Therapeutics, Inc.
    Inventors: Christopher G. M. Ken, Son M. Gia, Erik T. Engelson
  • Patent number: 5789018
    Abstract: This invention is in the general field of surgical instruments. It relates specifically to catheters which may be used in cardiovascular and endovascular procedures to deliver diagnostic, therapeutic, or vaso-occlusive agents to a target site within a human or animal body which is accessible by a system of natural passageways within that body. The catheters are coated in such a way that they are exceptionally slippery and the coating is very durable. The invention also relates to methods of coating the catheters and to methods of applying lubricious coatings by forming a sheet of the coating on the substrate and simultaneously drying and crosslinking through heat and radiation.
    Type: Grant
    Filed: February 21, 1996
    Date of Patent: August 4, 1998
    Assignee: Target Therapeutics, Inc.
    Inventors: Erik T. Engelson, Robert Hergenrother, Joseph Eder
  • Patent number: 5769796
    Abstract: This is a composite guidewire for use in a catheter and is used for accessing a targeted site in a lumen system of a patient's body. The guidewire core or guidewire section may be of a stainless steel or a high elasticity metal alloy, preferably a Ni--Ti alloy, also preferably having specified physical parameters. The composite guidewire assembly is especially useful for accessing peripheral or soft tissue targets. Variations include multi-section guidewire assemblies having (at least) super-elastic distal portions and super-elastic braided reinforcements along the mid or distal sections. A variation of the inventive guidewire includes the coating of the wire with a tie layer and then with a one or more lubricious polymers to enhance its suitability for use within catheters and with the interior of vascular lumen.
    Type: Grant
    Filed: January 22, 1997
    Date of Patent: June 23, 1998
    Assignee: Target Therapeutics, Inc.
    Inventors: Thomas J. Palermo, Gene Samson, Gregory E. Mirigian, U. Hiram Chee, Erik T. Engelson, Edward Snyder
  • Patent number: 5749891
    Abstract: This is an implantable vaso-occlusive device. It is a complex, helically wound coil having multiple secondary layers of primary windings. The final shape is often chunky in nature and may be used in the approximate shape of an anatomical cavity. It may be deployed in the approximate shape of a sphere, an ovoid, or other distorted spherical shape. The device is a self-forming shape made from a pre-formed linear vaso-occlusion member. Fibers may be introduced onto the device and affixed to the pre-formed linear member. The constituent member may be also be covered with a fibrous braid. The device is typically introduced through a catheter. The device is passed axially through the catheter sheath and assumes its form upon exiting the catheter without further action. The invention also includes methods of winding the anatomically shaped vaso-occlusive device into appropriately shaped forms and annealing them to form various devices.
    Type: Grant
    Filed: January 7, 1997
    Date of Patent: May 12, 1998
    Assignee: Target Therapeutics, Inc.
    Inventors: Christopher G. M. Ken, Erik T. Engelson